← Leaderboards
Kafait U Malik
University Of Tennessee Health Sci Ctr
$18,371,831
Attributed
$18,371,831
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,371,831 · 3
By mechanism
R01$17,227,411 · 2
T32$1,144,420 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tennessee Health Sci Ctr
Same institution · by research overlap
- Hao Chen$8,407,311
- Linda K. Myers$3,788,393
- Megan Kathleen Mulligan$3,609,287
- Andrew H Kang$3,547,325
Others in their field
Top investigators on “Angiotensin Ii”
- Mohan K. Raizada · University Of Florida$19,287,938
- Kenneth E Bernstein · Cedars-Sinai Medical Center$17,065,622
- David G Harrison · Vanderbilt University Medical Center$15,672,369
- Lisa A Cassis · University Of Kentucky$14,214,826
- Kathryn L Sandberg · Georgetown University$13,815,955
- Sadashiva S. Karnik · Cleveland Clinic Foundation$13,570,529
Research focus
Angiotensin IiEicosanoidsProstaglandinsCytochrome P450MetabolismProductionBlood VesselsKidneyReactive Oxygen SpeciesHypertensionBaseArachidonic AcidsAngiotensinsAdrenergic AgentsBlood PressureMolecularInhibitor/AntagonistVascular DiseasesBiochemicalHeartPlasmaAdenovirusesPathogenesisEnzymes
Grant awards (39)
Angiotensins, Prostaglandins and Adrenergic Interactions$763,156
R01 · FY2025 · HL · contact PI
Angiotensins, Prostaglandins and Adrenergic Interactions$747,893
R01 · FY2024 · HL · contact PI
Angiotensins, Prostaglandins and Adrenergic Interactions$763,156
R01 · FY2023 · HL · contact PI
Angiotensins, Prostaglandins-Adrenergic Interactions$643,123
R01 · FY2021 · HL · contact PI
Angiotensins, Prostaglandins-Adrenergic Interactions$643,123
R01 · FY2020 · HL · contact PI
Angiotensins, Prostaglandins-Adrenergic Interactions$643,123
R01 · FY2019 · HL · contact PI
Angiotensins, Prostaglandins-Adrenergic Interactions$717,765
R01 · FY2018 · HL · contact PI
Angiotensins, Prostaglandins-Adrenergic Interactions$579,576
R01 · FY2017 · HL · contact PI
Angiotensins, Prostaglandins-Adrenergic Interactions$565,592
R01 · FY2016 · HL · contact PI
Angiotensins, Prostaglandins-Adrenergic Interactions$555,926
R01 · FY2015 · HL · contact PI
Eicosanoid-Induced Vascular Growth During Injury$380,455
R01 · FY2015 · HL · contact PI
Angiotensins, Prostaglandins-Adrenergic Interactions$552,012
R01 · FY2014 · HL · contact PI
Eicosanoid-Induced Vascular Growth During Injury$378,525
R01 · FY2014 · HL · contact PI
Angiotensins, Prostaglandins-Adrenergic Interactions$592,283
R01 · FY2013 · HL · contact PI
Eicosanoid-Induced Vascular Growth During Injury$367,710
R01 · FY2013 · HL · contact PI
Angiotensins, Prostaglandins-Adrenergic Interactions$555,694
R01 · FY2012 · HL · contact PI
Eicosanoid-Induced Vascular Growth During Injury$399,162
R01 · FY2012 · HL · contact PI
Angiotensins, Prostaglandins-Adrenergic Interactions$550,190
R01 · FY2011 · HL · contact PI
Angiotensins, Prostaglandins-Adrenergic Interactions$556,276
R01 · FY2010 · HL · contact PI
Angiotensins, Prostaglandins-Adrenergic Interactions$551,093
R01 · FY2009 · HL · contact PI
Ecosanoids-Induced Vascular Growth During Injury$346,086
R01 · FY2009 · HL · contact PI
Angiotensins, Prostaglandins-Adrenergic Interactions$581,290
R01 · FY2008 · HL · contact PI
Ecosanoids-Induced Vascular Growth During Injury$346,086
R01 · FY2008 · HL · contact PI
Angiotensins, Prostaglandins-Adrenergic Interactions$22,195
R01 · FY2008 · HL · contact PI
Ecosanoids-Induced Vascular Growth During Injury$346,086
R01 · FY2007 · HL · contact PI
Lipid/Lipoprotein Metabolism and Cardiovascular Diseases$207,568
T32 · FY2007 · HL · contact PI
ANGIOTENSINS, PROSTAGLANDINS-ADRENERGIC INTERACTIONS$508,009
R01 · FY2006 · HL · contact PI
Ecosanoids-Induced Vascular Growth During Injury$356,423
R01 · FY2006 · HL · contact PI
Lipid/Lipoprotein Metabolism and Cardiovascular Diseases$299,956
T32 · FY2006 · HL · contact PI
ANGIOTENSINS, PROSTAGLANDINS-ADRENERGIC INTERACTIONS$505,080
R01 · FY2005 · HL
Ecosanoids-Induced Vascular Growth During Injury$365,000
R01 · FY2005 · HL
Lipid/Lipoprotein Metabolism and Cardiovascular Diseases$75,605
T32 · FY2005 · HL
ANGIOTENSINS, PROSTAGLANDINS-ADRENERGIC INTERACTIONS$490,370
R01 · FY2004 · HL
Lipid/Lipoprotein Metabolism and Cardiovascular Diseases$290,884
T32 · FY2004 · HL
ANGIOTENSINS, PROSTAGLANDINS-ADRENERGIC INTERACTIONS$476,086
R01 · FY2003 · HL
Lipid/Lipoprotein Metabolism and Cardiovascular Diseases$270,407
T32 · FY2003 · HL
ANGIOTENSINS, PROSTAGLANDINS-ADRENERGIC INTERACTIONS$501,578
R01 · FY2002 · HL
ANGIOTENSINS, PROSTAGLANDINS--ADRENERGIC INTERACTIONS$419,456
R01 · FY2001 · HL
ANGIOTENSINS, PROSTAGLANDINS--ADRENERGIC INTERACTIONS$457,833
R01 · FY2000 · HL